Commerz sees trade green shoots as vaccine update boosts stock

By Jasper Cox
12 Nov 2020

Commerzbank has endured a tough year but, with a new strategy on the way, loan impairments lower than at many peers, and executives seeing an uptick in its trade finance business, the worst may be behind it.

Bank share prices rocketed at the beginning of the week after a positive update on the effectiveness of the coronavirus vaccine being developed by Pfizer and BioNTech. Commerzbank was one of the big winners, with its price up roughly 20% this week so far, much higher than gains ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial